The American Association of Equine Practitioners has released a "Prescription for Racing Reform" that includes "a commitment to identifying non-race day treatment alternatives for exercise-induced pulmonary hemorrhage."
The second day of the inaugural Pan American Conference focused on medication policy and reform.
Gulfstream Park will begin third-party administration of race-day furosemide beginning Wednesday, Nov. 19.
Jockey Club says a recent study's findings challenge long-held opinions in North American racing, including the contention that the use of the diuretic furosemide is necessary to ensure long-term careers of horses.
A study published online this spring found no link between the vast majority of horses who suffer from exercise-induced pulmonary hemorrhage and long-term racing performance.
The National Horsemen's Benevolent and Protective Association restated its strong support for the continued use of Lasix (furosemide, also commonly called Salix) at its summer convention Aug.15-17 in Oklahoma City.
A new study finds no difference in the racing career longevity between horses who experience some level of exercise-induced pulmonary hemorrhage and those who never experience EIPH.
Though People for the Ethical Treatment of Animals has submitted a 10-page complaint and a 22-minute video to the KHRC alleging animal abuse in trainer Steve Asmussen's Churchill Downs stable, no smoking gun is evident.
Study finds 2-year-olds racing without race-day furosemide at 2013 Breeders' Cup World Championships at Santa Anita Park had fewer and less severe EIPH instances than juveniles who raced with the diuretic that weekend at SA.
Treatment of exercise-induced pulmonary hemorrhage by non-medicinal means was discussed April 9 during a seminar that focused on use of FLAIR Nasal Strips.
Among the speakers for an April 9 seminar on exercise-induced pulmonary hemorrhage are three trainers, officials announced.
Just days before the Breeders' Cup board of directors conducted a vote on Salix use at its world championships, prominent owners Gary and Mary West threatened litigation against the organization.
A group of scientists met with representatives of the Thoroughbred Owners of California Jan. 18 to discuss exercise-induced pulmonary hemorrhaging and later issued a joint statement supporting use of furosemide.
Trainers Todd Pletcher and Mark Casse took issue with the Breeders' Cup decision banning the anti-bleeding medication furosemide in this year's five juvenile races during the World Thoroughbred Championships.
Racing consultant Earl Ola talks about the relationship between conditioning and exercise-induced pulmonary hemorrhaging (EIPH), also known as bleeding read blog
Stewards at Turfway Park have slapped trainer Bret Calhoun with a 30-day suspension after a horse in his care tested positive for the prohibited anti-hypertension drug Guanabenz following a win at Churchill Downs May 26.
The Association of Racing Commissioners International is reassessing its policy supporting race-day administration of furosemide, but also indicated much needs to be done before any change is made.
The pros and cons of race-day medication in racehorses were debated Nov. 14 during a lengthy meeting of the Kentucky Horse Racing Commission Race Day Medication Committee at the state Capitol.
What is the breeding industry's responsibility in identifying stallions with EIPH? Read Blog
A South African study showed a strong heritability between some stallions and exercise-induced pulmonary hemorrhaging, also known as bleeding.
A well-attended summit June 13 at Belmont Park shed a lot of light on the research and international regulations surrounding the race-day medication Salix.
The medication summit will shed plenty of light on how the U.S. can improve its policies. Read Blog
- By Blood-Horse Staff
- International, Northeast Region, Midwest Region, Southeast Region, Southwest Region, West Region, Kentucky
The first international summit on race-day medication as it relates to exercise-induced pulmonary hemorhaging will be June 13-14 at Belmont Park.
Jockey Club president James Gagliano reiterates call for ban on race-day medications.
A groundbreaking study to be published in the Journal of the American Veterinary Medical Association shows that furosemide does more than enhance performance in Thoroughbred racehorses; it also has beneficial effects on the health and welfare of those horses.
The American Association of Equine Practitioners (AAEP) is seeking proposals to research the efficacy of adjunct bleeder medications, such as aminocaproic acid and/or conjugated estrogens, as a race day medication for prevention of exercise-induced pulmonary hemorrhage (EIPH).
Most Popular Stories
- Large Crowd Watches American Pharoah Gallop
- Badilla Earns Emotional Win at Golden Gate
- Team Texas Red Partners With TV Star
- More Than Just a Name for Run for Retts
- Shadwell Sire Bahri Pensioned in England
- Lubash Takes West Point for Second Time
- Champion Divine Fortune Dies After Fall
- American Pharoah Takes Easy Gallop at Spa
- NBC Schedules Two-Hour Travers Broadcast
- Belmont Winner Palace Malice Retired